Megval 50mg Injection: Effective Medication for Your Needs

Uses:

• Multiple myeloma (a type of cancer of the bone marrow);
• Advanced ovarian cancer;
• Childhood neuroblastoma (cancer of the nervous system);
• Malignant melanoma (skin cancer);
• Soft tissue sarcoma (cancer of the muscle, fat, fibrous tissue, blood vessels, or other supporting tissues of the body).

How it works:

• Megval 50mg Injection is an alkylating agent that reduces the number of abnormal cells in the body by cross-linking DNA and RNA strands and inhibiting protein synthesis.

Important information:

• Do not take if allergic to melphalan or any other ingredients;
• Inform your physician if you have had radiotherapy or cancer chemotherapy, have kidney problems, or are pregnant or planning pregnancy;
• Report any rash, lumps, hives, swollen face, eyelids, lips, sudden wheeziness, or chest tightness after taking the medicine.

Interaction with other drugs:

• Inform your healthcare provider about all the medicines you take, as certain medications can interact with Megval 50mg Injection and reduce its effectiveness.

Storage:

• Store in a refrigerator, 2° to 8°C;
• Protect from light and excessive moisture;
• Keep out of reach of children and pets.

Administration:

• Administered by a doctor or healthcare professional in a hospital setting;
• Can be given as an infusion into a vein or as a perfusion to a particular part of the body through an artery;
• Dose, route of administration, and duration of therapy determined by your doctor based on disease status, severity, and other factors.

Safety advice:

• Pregnancy: do not take if pregnant as it may harm the unborn baby;
• Breastfeeding: breastfeeding is not recommended;
• Lungs: consult your doctor if you have any lung diseases;
• Liver: consult your doctor if you have any liver diseases;
• Alcohol: it is not known whether it is safe to consume alcohol with Megval 50mg Injection;
• Driving: it is not known whether Megval 50mg Injection alters the ability to drive.

Side effects:

• Common: decreased blood cell count, nausea, vomiting, diarrhea, mouth ulcers, hair loss;
• Serious: cardiac arrest, liver inflammation, hypersensitivity skin reactions, acute renal failure, lung inflammation.

Word of advice:

• This medicine may cause changes in your blood levels, so your doctor may advise you to take certain blood tests during treatment;
• Do not take an extra dose to make up for a missed dose;
• This medicine could cause infertility, so talk with your doctor before using it if you are planning for pregnancy;
• This medicine may make you bleed, bruise, or get infections more easily, so take precautions to prevent illness and injury.

FAQs:

1. Can a patient with kidney problems take Megval 50mg Injection?

• Megval 50mg Injection should be cautiously taken if you have any kidney problems. Dose adjustments are necessary for patients with kidney diseases. Inform your doctor if you are on dialysis and have any kidney disorders.

2. Does Megval 50mg Injection weaken the immune system?

• The medicine can suppress your immune system and increase your chances of getting infections. Take precautions to prevent illness and injury.

3. What if I overdose or take two doses of Megval 50mg Injection?

• If you unknowingly overdosed or took two doses of Megval 50mg Injection, immediately inform your healthcare professional and seek medical advice.

4. What if I miss a dose of Megval 50mg Injection?

• Do not miss your dose. Keep all your appointments with the dosing regularly. In case, if you forgot or missed an appointment, inform your healthcare professional and reschedule the dosing.

5. Does Megval 50mg Injection cause hair loss?

• Thinning or loss of your hair will usually start within two to four weeks of your first dose of Megval 50mg Injection. You may also have thinning or loss of eyelashes, eyebrows, and other body hair. Consult your doctor if you have excessive hair loss.

Fact box:

• Molecule name: Melphalan;
• Therapeutic class: Antineoplastics;
• Pharmacological class: Alkylating agents;
• Indications: multiple myeloma, advanced ovarian cancer, childhood neuroblastoma, malignant melanoma, soft tissue sarcoma.

Tags: megval, injection, 50mg, medical-drug, pharmaceutical, healthcare